Ultragenyx Pharmaceutical Inc. Share Price
Equities
RARE
US90400D1081
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.9 USD | -0.78% | -4.33% | -14.47% |
05-03 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
05-02 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |
Sales 2024 * | 512M 40.87B | Sales 2025 * | 627M 50.06B | Capitalization | 3.4B 271B |
---|---|---|---|---|---|
Net income 2024 * | -560M -44.72B | Net income 2025 * | -476M -38.02B | EV / Sales 2024 * | 6.1 x |
Net cash position 2024 * | 274M 21.85B | Net cash position 2025 * | 337M 26.93B | EV / Sales 2025 * | 4.88 x |
P/E ratio 2024 * |
-6.23
x | P/E ratio 2025 * |
-7.82
x | Employees | 1,276 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.9% |
Latest transcript on Ultragenyx Pharmaceutical Inc.
1 day | -0.78% | ||
1 week | -4.33% | ||
Current month | -3.86% | ||
1 month | -20.75% | ||
3 months | -12.48% | ||
6 months | +17.23% | ||
Current year | -14.47% |
Managers | Title | Age | Since |
---|---|---|---|
Emil Kakkis
FOU | Founder | 63 | 21/04/10 |
Howard Horn
DFI | Director of Finance/CFO | 47 | 15/10/23 |
Eric Crombez
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Deborah Dunsire
BRD | Director/Board Member | 61 | 05/04/17 |
Emil Kakkis
FOU | Founder | 63 | 21/04/10 |
Daniel Welch
CHM | Chairman | 66 | 07/04/15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.21% | 0 M€ | -2.17% | - | |
0.82% | 4 M€ | +20.15% | ||
0.43% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
10/05/24 | 40.9 | -0.78% | 549,642 |
09/05/24 | 41.22 | -0.82% | 407,732 |
08/05/24 | 41.56 | -0.95% | 764,567 |
07/05/24 | 41.96 | -2.44% | 842,499 |
06/05/24 | 43.01 | +0.61% | 1,099,857 |
Delayed Quote Nasdaq, May 10, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.47% | 3.42B | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- RARE Stock